ROCKVILLE, Md., Jan. 12, 2016 /PRNewswire-USNewswire/ -- Major Depressive Disorder (MDD) can touch all aspects of a child's life. According to the journal Child and Adolescent Psychiatric Clinics of North America, it is estimated that approximately 1 percent to 2 percent of children and 3 percent to 8 percent of adolescents have depression. Many children and adolescents experience not only moodiness or sadness but may also experience and report a variety of symptoms and behaviors such as not feeling well, refusing to go to school, excessive worrying, reduced interest in activities, sudden changes in sleep or weight, or getting in trouble at school.
Although, there are a number of treatment options available for pediatric depression, including medication and psychotherapy, there remains a need for continued research.
The Engage clinical research studies are now seeking patients to evaluate the safety and effectiveness of two different investigational drugs in children and adolescents with MDD. Children and adolescents ages 7 to 17 who have been diagnosed with MDD or have been struggling with feelings of depression may be eligible to participate in an Engage clinical research study.
About 1,100 children and adolescents will participate in the Engage clinical research studies.
To learn more about the Engage clinical research studies or to find out if your child may be eligible to participate, visit www.TheEngageStudies.com or call 888-633-8909.
SOURCE Engage clinical research study